| Literature DB >> 23236935 |
Naohiro Ohshita1, Yasuo M Tsutsumi, Asuka Kasai, Tomohiro Soga, Tomomi Kanamura, Toshiko Katayama, Akio Iseki, Yoshinobu Tomiyama, Katsuya Tanaka.
Abstract
Anaphylaxis during anesthesia is a rare but life-threatening event. Sugammadex is a recently introduced drug that was specifically designed for the reversal of rocuroium and vecuronium-induced neuromuscular block. We describe the cases of a 74-year-old man and a 29-year-old man who developed an anaphylactoid reaction to sugammadex, presenting with cardiovascular collapse. Initial management consisted of fluid administration and intermittent i.v. ephedrine, epinephrine, and hydrocortisone. The patients made uncomplicated recovery and were discharged.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23236935
Source DB: PubMed Journal: Masui ISSN: 0021-4892